Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 12/20 | 0.67 |
| ▸ | ADRA2B | P18089 | 11/20 | 0.67 |
| ▸ | ADRA2C | P18825 | 11/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 10/20 | 0.67 |
| ▸ | ADRA1D | P25100 | 10/20 | 0.67 |
| ▸ | ADRA1B | P35368 | 9/20 | 0.67 |
| ▸ | HTR7 | P34969 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8690213 | 0.99 | ADRA2A (0.66) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL7028091 | 0.81 | ADRA2A (1.00) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| Povafonidine SCHEMBL6581181 | 0.78 | ADRA2A (0.67) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL6579433 | 0.78 | ADRA2A (0.64) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| Povafonidine SCHEMBL8927783 | 0.77 | ADRA2A (0.66) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL7742097 | 0.77 | ADRA2A (0.55) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL8117240 | 0.76 | ADRA2C (0.55) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL1670230 | 0.76 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| Hydrochloric Acid SCHEMBL8111465 | 0.75 | ADRA2C (0.53) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL7202832 | 0.75 | ADRA2A (0.62) | ADRA2AADRA2BADRA2CADRA1AADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423724-B1 | PREVENTION, THERAPY DISEASE | THE PROCTER & GAMBLE COMPANY | 2002-07-23 | — | — | US | disclosed |
| CN-1085945-C | 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists | PROCTER & GAMBLE (US) | 2002-06-05 | — | — | CN | disclosed |
| US-5916900-A | TREATMENT OF NASAL CONGESTION, ASTHMA, COUGH, CARDIOVASCULAR DISORDERS, OCULAR DISORDERS, GASTROINTESTINAL DISORDERS, MIGRAINES, SUSBSTANCE ABUSE | THE PROCTER & GAMBLE COMPANY (US) | 1999-06-29 | — | — | US | disclosed |
| US-5716966-A | RESPIRATORY SYSTEM DISORDERS; VISION DEFECTS; GASTROINTESTINAL DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-10 | — | — | US | disclosed |
| CN-1137754-A | 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists | PROCTER & GAMBLE (US) | 1996-12-11 | — | — | CN | disclosed |
| US-5576437-A | 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists | THE PROCTER & GAMBLE COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| EP-0734261-A1 | 7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-02 | — | — | EP | disclosed |
| WO-1995020386-A1 | 7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1995-08-03 | — | — | WO | disclosed |